FindTrial
Sign In

Mortality, Morbidity and Cost attributable to Health Care-Associated Infection

Study of Mortality, Morbidity and Cost attributable to Health Care-Associated Infection in a Tertiary Level Healthcare Institution

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/05/014330
Enrollment
31
Registered
2018-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- healthcare acquired infections (VAP & CLABSI)

Interventions

Intervention1: NIL: Nil

Sponsors

Max Super Specialty Hospital Saket New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Lab confirmed VAP Cases (CDC criteria) in the identified ICU during the selected time period. 2. Lab confirmed CLABSI Cases (CDC criteria) in the identified ICU during the selected time period. 3. All above Age groups of 18 years.

Exclusion criteria

Exclusion criteria: 1. Patients discharged before 48 hours of admission. 2. Patients diagnosed with infection before admission to selected ICU. 3. Patients already on Mechanical ventilation and transferred in ICU from outside 4. Patients already on Central Line and transferred in ICU from outside 5. Patients going in for emergency surgeries.

Design outcomes

Primary

MeasureTime frame
VAP Rate CLABSI rate Length of Stay in infected cases Cost attributable to infections mortality attributable to infectionsTimepoint: 2 years—

Secondary

MeasureTime frame
Impact of training on KAP scoresTimepoint: 4 months—

Countries

India

Contacts

Public ContactGinny Kaushal

Bharati Vidyapeeth University Medical College,

prakash.doke@gmail.com9623450225

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026